Ian Read joined Population Health Partners as a partner in 2021.
Ian has a 42-year track record as one of the foremost leaders, dealmakers, and shareholder value creators in the global biopharmaceutical industry. He was Chairman and Chief Executive Officer of Pfizer from December 2010 until January 2019, and Executive Chairman until December 2019. He oversaw over 30 new drug approvals, $88 billion in acquisition and divestiture deals, and a total shareholder return of 250%—representing over $242 billion in value creation.
Ian oversaw a period of industry-shaping innovation regarding the structure of Pfizer and its portfolio, including novel spin-outs and acquisitions alongside dozens of major licensing agreements.
Ian is lead independent director at Kimberly Clark, Chairman of DXC Technology and a founding member of the Board of Directors of Viatris. He is also an Operating Executive at the Carlyle Group.
Ian received his BSc in chemical engineering from London University Imperial College and earned his Chartered Accountants certification from the Institute of Chartered Accountants of England and Wales.